A98.8

Clinical Causes: Different types of viruses within various families, including Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae Transmission through contact with infected animals or humans, including bites, blood, bodily fluids, or contaminated environments Infection following exposure to insect vectors such as mosquitoes and ticks in endemic areas In some cases, laboratory exposure or contaminated medical supplies

Key Symptoms: High fever that develops rapidly Intense muscle aches and weakness Bleeding manifestations such as bleeding gums, nosebleeds, hematemesis (vomiting blood), or blood in stools Skin rash or petechiae (small red or purple spots due to bleeding under the skin) Gastrointestinal symptoms including nausea, vomiting, and abdominal pain Confusion, dizziness, or neurological symptoms in severe cases Progression to shock, organ failures, and potentially death if untreated

Diagnosis Path: Diagnosis involves a combination of clinical assessment and laboratory testing. Healthcare professionals may perform blood tests to detect specific viral RNA, antibodies, or antigens. In addition, disease history, exposure risks, and disease progression are crucial for accurate diagnosis. Laboratory confirmation is essential to differentiate these fevers from other infectious diseases with similar symptoms.

Treatment Protocols: Currently, there are no specific antiviral medications approved for all viral hemorrhagic fevers. Supportive care remains the mainstay of treatment and includes maintaining fluid and electrolyte balance, oxygen therapy, and monitoring vital signs. Severe cases may require hospitalization for intensive supportive measures, including blood transfusions and organ support. Prevention strategies involve minimizing exposure risks, practicing safe handling of blood and bodily fluids, and vaccination where available.